Add like
Add dislike
Add to saved papers

Inverse Relationship of Subjective Daytime Sleepiness to Sympathetic Activity in Heart Failure Patients with Obstructive Sleep Apnea.

Chest 2012 April 27
Abstract BACKGROUND:Patients with heart failure (HF) and obstructive sleep apnea (OSA) are less sleepy than patients with OSA, but without HF. Furthermore, unlike the non-HF population, in the HF population the degree of daytime sleepiness was not related to the apnea-hypopnea index (AHI). The sympathetic nervous system plays a critical role in alertness. HF and OSA both increase sympathetic nervous system activity (SNA) during wakefulness. We hypothesized that in HF patients with OSA, the degree of subjective daytime sleepiness will be inversely related to SNA. METHODS:Daytime muscle SNA (MSNA) was recorded in HF patients with OSA. Subjective daytime sleepiness was assessed by the Epworth Sleepiness Scale (ESS). RESULTS:We studied 27 patients with HF and OSA and divided them into two groups based on the median ESS score: a less sleepy group with an ESS score <6 (n=13) and a sleepier group with an ESS score ≥6 (n=14). The less sleepy group had higher MSNA (82.5±9.9 vs 69.3±18.6 bursts per 100 cardiac cycles, p=0.037) and a longer sleep onset latency (33±29 vs 14±13 minutes, p=0.039) than the sleepier group. The ESS score was inversely related to MSNA (r = -0.63, p<0.001), but not to the AHI, arousal index or indices of oxygen desaturation. CONCLUSIONS:In patients with HF and OSA, the degree of subjective daytime sleepiness is inversely related to MSNA. This relationship is likely mediated via central adrenergic alerting mechanisms. These findings help to explain the previously reported lack of daytime hypersomnolence in patients with HF and OSA.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app